XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 24, 2017
Jun. 25, 2017
[1]
ASSETS    
Cash and cash equivalents $ 2,406,462 $ 2,377,534
Investments 3,775,925 3,663,628
Accounts receivable, less allowance for doubtful accounts of $5,271 as of September 24, 2017, and $5,103 as of June 25, 2017 1,530,762 1,673,398
Inventories 1,328,297 1,232,916
Prepaid expenses and other current assets 187,334 195,022
Total current assets 9,228,780 9,142,498
Property and equipment, net 745,600 685,595
Restricted cash and investments 256,045 256,205
Goodwill 1,484,030 1,385,673
Intangible assets, net 420,359 410,995
Other assets 263,812 241,799
Total assets 12,398,626 12,122,765
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Trade accounts payable 471,805 464,643
Accrued expenses and other current liabilities 1,078,998 969,361
Deferred profit 597,921 607,672
Current portion of convertible notes and capital leases 639,907 908,439
Total current liabilities 2,788,631 2,950,115
Senior notes, convertible notes, and capital leases, less current portion 1,793,477 1,784,974
Income taxes payable 129,611 120,178
Other long-term liabilities 278,733 280,186
Total liabilities 4,990,452 5,135,453
Commitments and contingencies
Temporary equity, convertible notes 136,996 169,861
Stockholders’ equity:    
Preferred stock, at par value of $0.001 per share; authorized - 5,000 shares, none outstanding 0 0
Common stock, at par value of $0.001 per share; authorized, 400,000 shares; issued and outstanding, 162,144 shares at September 24, 2017, and 161,723 shares at June 25, 2017 162 162
Additional paid-in capital 5,891,549 5,845,485
Treasury stock, at cost; 107,360 shares at September 24, 2017, and 105,569 shares at June 25, 2017 (5,375,920) (5,216,187)
Accumulated other comprehensive loss (52,787) (61,700)
Retained earnings 6,808,174 6,249,691
Total stockholders’ equity 7,271,178 6,817,451
Total liabilities and stockholders’ equity $ 12,398,626 $ 12,122,765
[1] Derived from audited financial statements